Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age-related macular degeneration

Abstract The clinical implication of en face imaging of Haller vessels and macular neovascularization (MNV) in neovascular age-related macular degeneration (nAMD) is not well established. The purpose of this study is to investigate whether the early-phase morphology of en face Haller vessel and MNV...

Full description

Bibliographic Details
Main Authors: Hyungwoo Lee, SoHyeon Kim, Myung Ae Kim, Hyewon Chung, Hyung Chan Kim
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-15139-0
_version_ 1811334618236846080
author Hyungwoo Lee
SoHyeon Kim
Myung Ae Kim
Hyewon Chung
Hyung Chan Kim
author_facet Hyungwoo Lee
SoHyeon Kim
Myung Ae Kim
Hyewon Chung
Hyung Chan Kim
author_sort Hyungwoo Lee
collection DOAJ
description Abstract The clinical implication of en face imaging of Haller vessels and macular neovascularization (MNV) in neovascular age-related macular degeneration (nAMD) is not well established. The purpose of this study is to investigate whether the early-phase morphology of en face Haller vessel and MNV is related to the injection frequency and visual outcome in treatment-naïve nAMD. En face images of Haller vessel and MNV were acquired from 52 eyes at baseline, after three loading doses and at 12 months later using optical coherence tomography (OCT) and OCT angiography. Vessel area, diameter, length, intersection number, fractal dimension, and lacunarity were calculated. Patients were classified according to the injection frequency (< 5 as the infrequent group) and visual gain (≥ 0.3 logMAR) over 12 months. The infrequent group was associated with a longer Haller vessel length after loading doses (OR 3.05, P = 0.01), while visual gain was associated with a smaller maximal MNV diameter after loading doses (OR 0.22, P = 0.03). A predictive model for frequent injection based on the Haller vessel length demonstrated an AUC of 0.71. In conclusion, the en face Haller vessel and MNV morphology after loading doses can be used as biomarkers for the injection frequency and visual gain during the first year in treatment-naïve nAMD patients.
first_indexed 2024-04-13T17:10:47Z
format Article
id doaj.art-484e838917bb423a9c0a84e84745e158
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-13T17:10:47Z
publishDate 2022-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-484e838917bb423a9c0a84e84745e1582022-12-22T02:38:17ZengNature PortfolioScientific Reports2045-23222022-06-0112111010.1038/s41598-022-15139-0Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age-related macular degenerationHyungwoo Lee0SoHyeon Kim1Myung Ae Kim2Hyewon Chung3Hyung Chan Kim4Department of Ophthalmology, Konkuk University Medical Center, Konkuk University School of MedicineDepartment of Ophthalmology, Konkuk University Medical Center, Konkuk University School of MedicineDepartment of Ophthalmology, Konkuk University Medical Center, Konkuk University School of MedicineDepartment of Ophthalmology, Konkuk University Medical Center, Konkuk University School of MedicineDepartment of Ophthalmology, Konkuk University Medical Center, Konkuk University School of MedicineAbstract The clinical implication of en face imaging of Haller vessels and macular neovascularization (MNV) in neovascular age-related macular degeneration (nAMD) is not well established. The purpose of this study is to investigate whether the early-phase morphology of en face Haller vessel and MNV is related to the injection frequency and visual outcome in treatment-naïve nAMD. En face images of Haller vessel and MNV were acquired from 52 eyes at baseline, after three loading doses and at 12 months later using optical coherence tomography (OCT) and OCT angiography. Vessel area, diameter, length, intersection number, fractal dimension, and lacunarity were calculated. Patients were classified according to the injection frequency (< 5 as the infrequent group) and visual gain (≥ 0.3 logMAR) over 12 months. The infrequent group was associated with a longer Haller vessel length after loading doses (OR 3.05, P = 0.01), while visual gain was associated with a smaller maximal MNV diameter after loading doses (OR 0.22, P = 0.03). A predictive model for frequent injection based on the Haller vessel length demonstrated an AUC of 0.71. In conclusion, the en face Haller vessel and MNV morphology after loading doses can be used as biomarkers for the injection frequency and visual gain during the first year in treatment-naïve nAMD patients.https://doi.org/10.1038/s41598-022-15139-0
spellingShingle Hyungwoo Lee
SoHyeon Kim
Myung Ae Kim
Hyewon Chung
Hyung Chan Kim
Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age-related macular degeneration
Scientific Reports
title Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age-related macular degeneration
title_full Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age-related macular degeneration
title_fullStr Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age-related macular degeneration
title_full_unstemmed Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age-related macular degeneration
title_short Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age-related macular degeneration
title_sort morphology of en face haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age related macular degeneration
url https://doi.org/10.1038/s41598-022-15139-0
work_keys_str_mv AT hyungwoolee morphologyofenfacehallervesselandmacularneovascularizationatbaselineand3monthsaspredictivefactorsinagerelatedmaculardegeneration
AT sohyeonkim morphologyofenfacehallervesselandmacularneovascularizationatbaselineand3monthsaspredictivefactorsinagerelatedmaculardegeneration
AT myungaekim morphologyofenfacehallervesselandmacularneovascularizationatbaselineand3monthsaspredictivefactorsinagerelatedmaculardegeneration
AT hyewonchung morphologyofenfacehallervesselandmacularneovascularizationatbaselineand3monthsaspredictivefactorsinagerelatedmaculardegeneration
AT hyungchankim morphologyofenfacehallervesselandmacularneovascularizationatbaselineand3monthsaspredictivefactorsinagerelatedmaculardegeneration